A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets
Status:
Recruiting
Trial end date:
2023-05-30
Target enrollment:
Participant gender:
Summary
This study is conducted to investigate the pharmacokinetic and safety profiles of TQB3720 in
patients with metastatic castration-resistant prostate cancer.